Anne Zimmerman, editor-in-chief of the Columbia University online journal, <a href=" target="_blank">Voices in Bioethics ...

Ironwood Pharmaceuticals is a smaller company than it was in 2016, when Life Science Leader wrote a feature article about its ...

This presentation highlights key pharmaceutical launches anticipated in 2025, emphasizing their potential to address unmet needs across various medical fields. The document covers new developments in ...

Longer time horizons and therapeutic area expertise make philanthropy venture capital an attractive option for ...

Implementing AI in drug discovery offers significant potential for reducing operating costs, though the extent varies widely. A Deloitte report suggests AI could cut drug development costs by up to 70 ...

Job rotations provide an opportunity for promising, high-potential employees to grow and learn new parts of the business.

Spinogenix is using small molecule drugs to regenerate synapses in patients with ALS, Alzheimer's disease, schizophrenia, ...

As professionals within the life sciences industry, a new era is upon us, marked by the pursuit of efficiency. In part this has been driven by legislative measures such as the Inflation Reduction Act ...

This is the second article in a series on “putting people first” as a leader. Click here to read the first article in the series. I've always believed that the true measure of a company's success lies ...